Carmat Expands Its PIVOTAL Study Internationally, In Line With Its Clinical Strategy And CE Marking Process Post author:Sam Post published:October 5, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Panel Unanimously Endorses Novartis AG's CAR-T Leukemia Drug July 12, 2017 10 Biotechs Tackling Form of Aggressive Brain Cancer July 20, 2017 OPKO Health’s Annual Report a Mixed Bag March 1, 2018